Merck: Navigating Patent Cliff and Growth Prospects
Merck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Which rewards card is better for travel? Explore options to maximize your travel benefits and choose the right card for you.
22,786 articlesMerck faces the challenge of expiring patents while pushing a robust pipeline and disciplined capital moves. This gui...
Celsius has moved into the spotlight as a growth play in beverages. This article lays out five practical reasons Cels...
Investors face a choice between a high-growth gene-editing bet and a cash-generating biotech leader. This article bre...
A single Vanguard ETF has quietly led the charge over the past ten years by keeping costs ultra-low and sticking to t...
When public moments collide with private finances, everyone feels the ripple effects. This piece explores how leaders...
Want to decode finance america (foa) earnings? This investor's guide breaks down the numbers, explains what to watch ...
Navitas Semiconductor is pursuing an AI data-center power strategy built around 800V architecture. This move could re...
When a chief executive sells stock after exercising options, investors often wonder if confidence underpins the move....
Target is reeling from included margin pressure and a scale battle with bigger retailers, pushing investors to rethin...
Looking for steady income that stands the test of time? These three dividend stocks built last show how durable brand...
A rare setup has investors watching for a pattern not seen since 1871. This article explains what the stock market br...
What happens when a director chooses a real puppet over CGI? This finance-focused look at practical effects translate...